James Healy – Biography
Last update: April 18, 2026Executive profile
James was Board Member at ObsEva, and Board Member at Amarin Corporation. James Healy joined Sofinnova Partners in 2023.
James Healy is currentlyManaging Partner at Sofinnova Investments - View - Sofinnova Investments org chart
Director at Arrivent Biopharma - View - Arrivent Biopharma org chart
Director at BioAge - View - BioAge org chart
Director at Carbery - View - Carbery org chart
Director at Rapport Therapeutics - View - Rapport Therapeutics org chart
Create your alert
to follow the career of James Healy.
Education
James Healy has a Master of Medicine from Stanford University School of Medicine in 1998 and a PhD in Immunology from Stanford University in 1998.
They have also studied at Stanford University :
Find more alumni from Stanford University
More about James Healy
Selected links
Do you need to know more about James Healy? More results.
Participate
Social media
- James Healy on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of James Healy
The colleagues of James Healy
Company Colleagues
- At Sofinnova Investments, James Healy has 17 colleagues including Eric Delbridge (Portfolio & Public Equity), Debbie Murray (HR)…
- At Arrivent Biopharma, James Healy has 23 colleagues including Bing Yao (CEO & Director), Chris Nolet (Director)…
- At BioAge, James Healy has 18 colleagues including Kristen Fortney (CEO & Director), Patrick Enright (Director)…
- At Carbery, James Healy has 27 colleagues including Jason Hawkins (CEO), Jerry O'Neill (Director)…
- At Rapport Therapeutics, James Healy has 41 colleagues including Abraham Ceesay (CEO), Wendy Young (Director)…
Industry Colleagues
- In the Fund industry, James Healy has 30,040 colleagues in 1,643 companies located in 64 countries. 10,519 executive movements have been recorded in the last 12 months. Learn more about Fund.
Report an error
Update the org chart details of James Healy.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for James Healy.
